These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17075707)

  • 1. [Medicinal prevention of gastrointestinal tumors: aspirin, Helicobacter and more?].
    Becker JC; Domschke W; Pohle T
    Internist (Berl); 2006 Dec; 47(12):1229-30, 1232-4, 1236-8. PubMed ID: 17075707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
    Limmer S; Ittel TH; Wietholtz H
    Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helicobacter pylori and non-steroidal anti-inflammatory drugs: does infection affect the outcome of NSAID therapy?
    McCarthy DM
    Yale J Biol Med; 1998; 71(2):101-11. PubMed ID: 10378355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ulcer and gastritis.
    Wu JC; Sung JJ
    Endoscopy; 2002 Feb; 34(2):104-10. PubMed ID: 11822005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Helicobacter pylori eradication on anti-thrombotic dose aspirin-induced gastroduodenal mucosal injury.
    Giral A; Ozdogan O; Celikel CA; Tozun N; Ulusoy NB; Kalayci C
    J Gastroenterol Hepatol; 2004 Jul; 19(7):773-7. PubMed ID: 15209624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding NSAID-PPI-COX-2 interrelationships.
    Singh G
    Drugs Today (Barc); 2004 Mar; 40 Suppl A():21-4. PubMed ID: 15190384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of gastrointestinal cancer--the potential role of NSAIDs in colorectal cancer.
    Luk GD
    Schweiz Med Wochenschr; 1996 May; 126(19):801-12. PubMed ID: 8693304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen.
    Chan FK; Chung SC; Suen BY; Lee YT; Leung WK; Leung VK; Wu JC; Lau JY; Hui Y; Lai MS; Chan HL; Sung JJ
    N Engl J Med; 2001 Mar; 344(13):967-73. PubMed ID: 11274623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Should Helicobacter pylori infection be tested and eradicated in patients treated or about to be treated with aspirin or nonsteroidal anti-inflammatory drugs?].
    Thiéfin G
    Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 2):415-26. PubMed ID: 12700498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Who? When to treat? Gastritis, particular histological lesions, NSAID therapy and extradigestive diseases.
    Deprez P
    Acta Gastroenterol Belg; 1998; 61(3):307-12. PubMed ID: 9795461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current approaches to prevent NSAID-induced gastropathy--COX selectivity and beyond.
    Becker JC; Domschke W; Pohle T
    Br J Clin Pharmacol; 2004 Dec; 58(6):587-600. PubMed ID: 15563357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of peptic ulcer bleeding associated with Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs, low-dose aspirin, and antihypertensive drugs: a case-control study.
    Nagata N; Niikura R; Sekine K; Sakurai T; Shimbo T; Kishida Y; Tanaka S; Aoki T; Okubo H; Watanabe K; Yokoi C; Akiyama J; Yanase M; Mizokami M; Uemura N
    J Gastroenterol Hepatol; 2015 Feb; 30(2):292-8. PubMed ID: 25339607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should we eradicate Helicobacter pylori infection in patients receiving nonsteroidal anti-inflammatory drugs or low-dose aspirin?
    Chan FK
    Chin J Dig Dis; 2005; 6(1):1-5. PubMed ID: 15667550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The association between Helicobacter pylori and gastric cancer: the role of infection's eradication. Recent advances].
    Eusebi LH; Ceroni L; Laterza L; Kurelac I; Fuccio L
    Recenti Prog Med; 2010 Feb; 101(2):66-9. PubMed ID: 20433004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric cancer chemoprevention: the current evidence.
    Tan VP; Wong BC
    Gastroenterol Clin North Am; 2013 Jun; 42(2):299-316. PubMed ID: 23639642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment.
    Chan FK; Graham DY
    Aliment Pharmacol Ther; 2004 May; 19(10):1051-61. PubMed ID: 15142194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are COX-2 inhibitors preferable to non-selective non-steroidal anti-inflammatory drugs in patients with risk of cardiovascular events taking low-dose aspirin?
    Strand V
    Lancet; 2007 Dec; 370(9605):2138-51. PubMed ID: 18156036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of Helicobacter pylori in drug-induced gastrointestinal bleeding].
    Chaussade S; Abitbol V
    Presse Med; 2003 Nov; 32(37 Pt 2):S60-3. PubMed ID: 14763358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicobacter pylori infection, but not low-dose aspirin, results in a local reduction of the secretory leukocyte protease inhibitor in gastroduodenal mucosa.
    Wex T; Ye S; Treiber G; Vieth M; Roessner A; Malfertheiner P
    Helicobacter; 2006 Feb; 11(1):31-8. PubMed ID: 16423087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs, and gastroduodenal pathology: current status.
    Trifan A; Stan M; Stanciu GO; Malgarinos G; Stanciu C
    Rev Med Chir Soc Med Nat Iasi; 1999; 103(3-4):44-7. PubMed ID: 10756924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.